Ilse Roodink

Direttore Tecnico/Scientifico/R&S presso IMMUNOPRECISE ANTIBODIES LTD.

Patrimonio netto: 9 637 $ in data 30/06/2024

Health Technology

Consumer Services

Profilo

Ilse Roodink is currently the Chief Scientific Officer at ImmunoPrecise Antibodies Ltd.
She previously worked as the Scientific Director at Immunoprecise Antibodies (Europe) BV.
Dr. Roodink received her undergraduate, graduate, and doctorate degrees from Radboud University Nijmegen.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
IMMUNOPRECISE ANTIBODIES LTD. 0.04%	18/03/2024	9 542 ( 0.04% )	9 637 $	30/06/2024

Posizioni attive di Ilse Roodink

Società	Posizione	Inizio
IMMUNOPRECISE ANTIBODIES LTD.	Direttore Tecnico/Scientifico/R&S	01/07/2021

Tutte le posizioni attive di Ilse Roodink

Precedenti posizioni note di Ilse Roodink

Società	Posizione	Fine
Immunoprecise Antibodies (Europe) BV Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Immunoprecise Antibodies (Europe) BV operates as a pharmaceutical company that specializes in antibiotics. Its services include antigen selection, antibody generation, antibody optimization, antibody production, antibody processing and assay development. The company was founded in 2004 and is headquartered in Oss, the Netherlands.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Ilse Roodink

Formazione di Ilse Roodink

Radboud University Nijmegen

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ilse Roodink

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
IMMUNOPRECISE ANTIBODIES LTD.	Health Technology

Aziende private	1
Immunoprecise Antibodies (Europe) BV Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Immunoprecise Antibodies (Europe) BV operates as a pharmaceutical company that specializes in antibiotics. Its services include antigen selection, antibody generation, antibody optimization, antibody production, antibody processing and assay development. The company was founded in 2004 and is headquartered in Oss, the Netherlands.	Health Technology